ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

ONS Calls For Changes To Resolve Nurse Shortage

June 8, 2001

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013